Entrada Therapeutics (TRDA) Asset Utilization Ratio (2023 - 2025)
Historic Asset Utilization Ratio for Entrada Therapeutics (TRDA) over the last 3 years, with Q3 2025 value amounting to 0.14.
- Entrada Therapeutics' Asset Utilization Ratio fell 6229.9% to 0.14 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14, marking a year-over-year decrease of 6229.9%. This contributed to the annual value of 0.42 for FY2024, which is 1836.89% up from last year.
- Latest data reveals that Entrada Therapeutics reported Asset Utilization Ratio of 0.14 as of Q3 2025, which was down 6229.9% from 0.17 recorded in Q2 2025.
- In the past 5 years, Entrada Therapeutics' Asset Utilization Ratio ranged from a high of 0.44 in Q2 2024 and a low of 0.07 during Q1 2023
- Moreover, its 3-year median value for Asset Utilization Ratio was 0.27 (2023), whereas its average is 0.25.
- Its Asset Utilization Ratio has fluctuated over the past 5 years, first skyrocketed by 38905.37% in 2024, then plummeted by 6229.9% in 2025.
- Over the past 3 years, Entrada Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.27 in 2023, then surged by 44.23% to 0.39 in 2024, then tumbled by 63.39% to 0.14 in 2025.
- Its Asset Utilization Ratio was 0.14 in Q3 2025, compared to 0.17 in Q2 2025 and 0.34 in Q1 2025.